story of the week
T-DM1–Associated Cardiotoxicity in Advanced HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Emtansine (T-DM1)-Associated Cardiotoxicity: Pooled Analysis in Advanced HER2-Positive Breast Cancer
Eur. J. Cancer 2020 Feb 01;126(xx)65-73, N Pondé, L Amaye, M Lambertini, M Paesmans, M Piccart, E de AzambujaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.